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ABSTRACT: The Bacillus licheniformis BS3 â-lactamase catalyzes the hydrolysis of the â-lactam ring of
penicillins, cephalosporins, and related compounds. The production of â-lactamases is the most common
and thoroughly studied cause of antibiotic resistance. Although they escape the hydrolytic activity of the
prototypical Staphylococcus aureus â-lactamase, many cephems are good substrates for a large number
of â-lactamases. However, the introduction of a 7R-methoxy substituent, as in cefoxitin, extends their
antibacterial spectrum to many cephalosporin-resistant Gram-negative bacteria. The 7R-methoxy group
selectively reduces the hydrolytic action of many â-lactamases without having a significant effect on the
affinity for the target enzymes, the membrane penicillin-binding proteins. We report here the crystallographic
structures of the BS3 enzyme and its acyl-enzyme adduct with cefoxitin at 1.7 Å resolution. The
comparison of the two structures reveals a covalent acyl-enzyme adduct with perturbed active site
geometry, involving a different conformation of the ¿-loop that bears the essential catalytic Glu166 residue.
This deformation is induced by the cefoxitin side chain whose position is constrained by the presence of
the R-methoxy group. The hydrolytic water molecule is also removed from the active site by the 7â-
carbonyl of the acyl intermediate. In light of the interactions and steric hindrances in the active site of the
structure of the BS3-cefoxitin acyl-enzyme adduct, the crucial role of the conserved Asn132 residue is
confirmed and a better understanding of the kinetic results emerges.
â-Lactam antibiotics are widely used in antimicrobial
therapy because of their ability to inactivate DD-transpepti-
dases and/or DD-carboxypeptidases, also called penicillin-
binding proteins (or PBPs),1 which are essential enzymes in
bacterial cell wall synthesis. The natural substrates of these
enzymes are structurally similar to â-lactam-based com-
pounds.
An important phenomenon of resistance is caused by the
bacterial production of â-lactamases that rapidly hydrolyze
â-lactams and release inactive products. On the basis of their
catalytic mechanisms, â-lactamases are divided into two
groups. The first includes zinc enzymes that are indexed as
class B enzymes. All the other â-lactamases fall into a second
group of “active site” serine enzymes and together with PBPs
form the “penicilloyl serine transferase” superfamily (1).
According to their amino acid sequences, the serine â-lac-
tamases are subdivided into three classes (A, C, and D), but
they all follow a similar kinetic pathway schematically
represented by a simple three-step model:
where E is the enzyme, S the substrate, ES a noncovalent
Henri-Michaelis complex, ES* a covalent acyl-enzyme
adduct, and P the inactive degradation product of the
substrate. Usually, this reaction is characterized by the
classical Henri-Michaelis parameters kcat and Km describing
the maximum rate of hydrolysis and the substrate affinity,
respectively. Therefore, an efficient â-lactamase exhibits high
kcat and kcat/Km values, the latter reflecting the rate of
acylation. The same kinetic scheme applies to the interaction
between PBPs and â-lactams, but the value of k3 is very
low. The ideal therapeutic antibiotic would thus combine very
low kcat values with both PBPs and â-lactamases or, even
better, would not be recognized by the latter enzymes (very
low kcat/Km), while exhibiting a sufficient k2/K′ value (where
K′ ) k1 + k2/k1), at least 103 M-1 s-1 with PBPs.
Compared to “classical” cephems, cefoxitin, a semisyn-
thetic antibiotic, exhibits considerably decreased rates of both
acylation and deacylation with many class A â-lactamases,
whereas its affinity for most PBPs remains almost unchanged
(2). With class C â-lactamases, the acylation is rather
efficient, but the deacylation rate is slow (3). This behavior
is generally observed with compounds bearing a methoxy
side chain on the R-face of the â-lactam ring (Table 1).
Representative of the cephamycin group of antibiotics,
cefoxitin extends its antibacterial spectrum to many cepha-
losporin-resistant Gram-negative bacteria. Several kinetic and
modeling studies have already been performed on the
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reactions between various â-lactamases and compounds
bearing R-methoxy and C-3′ groups (2-7). They first showed
that the interaction between the Escherichia coli TEM-1 class
A â-lactamase and cefoxitin induced deformation of the
active site (5). This result was later confirmed by NMR
experiments on the acyl-enzyme adduct formed by the
â-lactamases of Bacillus licheniformis 749/C and cefoxitin
(4). It was also demonstrated that the kinetic pathway of a
class A â-lactamase with cefoxitin could be somehow
modified compared to the three-step model described above.
Formation of a second, more stable, acyl-enzyme ES**
results from the elimination of the C-3′ leaving group from
ES*. When this reaction is as fast as or faster than the
formation of ES*, the modified ES** adduct is the most
abundant steady-state intermediate (4, 6, 7). Molecular
modeling studies of cefoxitin with the â-lactamases from
Streptomyces albus G and B. licheniformis 749/C indicated
that the R-methoxy group of the substrate induced a
displacement of the so-called hydrolytic water molecule,
explaining the very low hydrolysis rates (7).
Here we report the 1.7 Å resolution crystal structures of
the BS3 â-lactamase and of its adduct with cefoxitin. The
complex is an acyl-enzyme intermediate where the C-3′
leaving group of cefoxitin has been eliminated. A comparison
with the unliganded BS3 structure clearly reveals significant
conformational modifications, arising from the adaptation of
the catalytic pocket ¿-loop to the steric hindrance of the
substrate 7â side chain. Our results confirm also the crucial
role of the conserved Asn132 residue for an adequate
positioning of â-lactam substrates.
MATERIALS AND METHODS
Protein Purification, Crystallization, and Data Collection.
The expression and purification of the BS3 enzyme were
performed according to the method of Ledent and co-workers
(8). The initial crystallization conditions for the BS3 enzyme
were determined using the Gridscreen, Crystalscreen, and
Crystalscreen II sparse matrix crystallization kits (Hampton
Research). Orthorhombic crystals were first obtained using
the hanging drop vapor diffusion method with drops contain-
ing 5 íL of a protein solution (10 mg/mL) and 5 íL of 25%
PEG 6000 in 100 mM sodium acetate buffer (pH 5.0),
equilibrated against 1 mL of the latter solution at 20 °C.
Monoclinic crystals were then obtained when the buffer
solution was changed to 100 mM sodium citrate (pH 5.0).
By increasing the protein concentration to 40 mg/mL and
lowering the PEG 6000 concentration and the pH of the
buffer to 10% and 3.4, respectively, we obtained very big
prismatic crystals of up to 1.0 mm3. The BS3-cefoxitin
adduct was obtained by diffusing into the crystals increasing
concentrations of cefoxitin over the course of 24 h at room
temperature. A fresh solution of cefoxitin was continuously
added up to a final concentration of 25 mM.
The first X-ray diffraction spectrum was obtained from
orthorhombic crystals collected at room temperature using
a Siemens X1000 area detector system with a conventional
rotating-anode generator as the X-ray source. This single
crystal, belonging to space group P212121 with unit cell
dimensions a ) 54.97 Å, b ) 87.03 Å, and c ) 110 Å, and
containing two molecules per asymmetric unit, diffracts to
only 2.4 Å resolution (8). All data with monoclinic crystals,
BS3 and the BS3-cefoxitin adduct, were collected at room
temperature at LURE (Orsay, France) on beamline D41A at
a wavelength of 1.375 Å using a Mar-Research image plate
detector. Indexing and integration were carried out using
MOSFLM version 5.41 (9), and the scaling of the intensity
data was accomplished with SCALA of the CCP4 program
suite (10). These crystals diffracted to 1.65 Å resolution, and
data statistics are given in Table 2. As the orthorhombic form,
the monoclinic crystals contain two molecules per asym-
metric unit but are characterized by a higher solvent content,
roughly 51% versus 40% for the orthorhombic form accord-
ing to Matthews’s coefficient (11).
Structure Determination and Refinement. As the amino
acid sequences of BS3 and of the B. licheniformis 749/C
â-lactamase (12) (PDB entry 4BLM) differ by only seven
residues, the structure of BS3 was determined by molecular
replacement with the AMORE package (13) using data of
the monoclinic crystals. The starting model was composed
of only one monomer of the 749/C structure, with water
molecules removed. The model was refined by simulated
annealing in X-PLOR (14) with a ó(F) cutoff of 2.0. At each
Table 1: Structure of Substrates and Kinetic Parameters Discussed in This Study
a Kinetic parameters were determined at 30 °C on the BS3 â-lactamase in 100 mM sodium citrate (pH 5.0). b The structure of moxalactam
contains an oxygen atom instead of a sulfur atom in position 1. c FMCA is 7â-formamidoyl-7R-methoxycephalosporanic acid. Kinetic parameters
for this compound were determined on the B. licheniformis 749/C â-lactamase at pH 7.0 (4).
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step of refinement (positions and temperature factors), the
2Fo - Fc and Fo - Fc electron density maps were calculated
using X-PLOR, and manual rebuilding was done in the
program TURBO-FRODO (15).
To determine the structure of the BS3-cefoxitin complex,
the dimer of the unliganded BS3 enzyme without active site
solvent molecules was used as the initial phasing model.
After rigid body refinement, the resulting model was used
to calculate the 2Fo - Fc and Fo - Fc maps, which revealed
perturbations of the ¿-loop defining a side of the catalytic
pocket, and a covalent bond between the active serine and
the substrate. The ¿-loop was rebuilt using an omit map
which excluded residues 166-170, and the cefoxitin was
built into the observed difference density. The complexed
structure was refined as the unliganded one, by several
alternating cycles of simulated annealing in X-PLOR and
model refitting in TURBO-FRODO.
For both structures, the two molecules of the asymmetric
unit were treated independently, without averaging, to
identify different eventual conformations. All atoms were
refined with an occupancy of 1.0, and only the first layer of
water molecules having a very well-defined electron density
and a temperature factor of <50.0 Å2 was considered. The
free enzyme and adduct structures were refined to 1.7 Å with
Rfree values of 23.5 and 25.6%, respectively. The statistics
of refinement are summarized in Table 3. Atomic coordinates
have been deposited in the Protein Data Bank (entries 1I2S
and 1I2W).
Citrate and Cefoxitin Parametrization. To include small
compounds (such as citrate in the free enzyme and cefoxitin
in the adduct) during the refinement processes, the topology
and parameter files suitable for X-PLOR had to be generated.
To do so, the small compounds were first constructed and
fitted in the electron density maps. All the degrees of freedom
describing the molecular geometry were then fully optimized
at the ab initio quantum chemistry level with the minimal
basis set MINI-1′ of Huzinaga (16, 17) using the minimiza-
tion procedures available in the Gaussian suite of programs
(18). The net charges were derived from Mulliken’s popula-
tion analysis scheme.
Determination of Kinetic Parameters. Benzylpenicillin was
from Rhoˆne-Poulenc, and cephalothin, cefoxitin, and moxa-
lactam were from Sigma. Kinetic parameters were deter-
mined at 30 °C in the indicated buffers. Complete time
courses of the hydrolysis of cephalothin and benzylpenicillin
were recorded at 260 and 235 nm, respectively, and the kcat/
Km values for these compounds were derived as described
by De Meester and co-workers (19). Hydrolysis of cefoxitin
and moxalactam was followed at 273 and 270 nm, respec-
tively, and kcat/Km values were obtained from initial rates of
hydrolysis at substrate concentrations well below the Km
(typically 100 íM).
RESULTS
OVerall Structure of the BS3 Enzyme. The crystallographic
structure of BS3 was determined to 1.7 Å resolution (Table
3) by molecular replacement using as a search model the
structure of the homologous â-lactamase of B. licheniformis
749/C (12). The BS3 crystal reveals two molecules per
asymmetric unit, which were refined independently with 260
amino acid residues. When compared, the two monomers
are very similar with an rms deviation of 0.22 Å between
the equivalent backbone atoms (N, CR, C, and O atoms).
As expected, the BS3 polypeptide chain exhibits the typical
fold of all known class A â-lactamases and is composed of
two globular domains. One domain is formed by a long
central R-helix (R2) surrounded by four R-helices (R4-R6
and R9) and four 310-helices (R30-R32 and R7). Just before
the helix R2, a one-turn 310-helix (R20) is formed. The second
domain consists of a five-stranded antiparallel â-sheet (â1-
â5) covered by the N- and C-terminal R-helices (R1 and
R11) and a short R-helix (R10) on one face and one R-helix
(R8) on the other face (Figure 1a).
The catalytic pocket is located at the interface between
the two domains. It is limited by four structural elements
well conserved among all class A â-lactamase structures.
The center of the substrate cavity is occupied by the Ser70-
Thr71-Ile72-Lys73 tetrad, including the nucleophilic serine
residue. One side of the cavity is defined by the Ser130-
Asp131-Asn132 loop, and the opposite side consists of the
Table 2: X-ray Data Collectiona
BS3 BS3-cefoxitin
space group P21 P21
cell parameters:
â (deg) 94.43 94.18








no. of measurements 165623 (64168) 143995 (54861)
no. of unique
reflections
70471 (27770) 68766 (26718)
completeness (%) 93.3 (89.7) 91.8 (87.1)
average I/ó(I) 5.4 (4.9) 5.0 (2.1)
Rmergeb (%) 4.8 (17.0) 7.2 (43.0)
a Data for the highest-resolution shell are in parentheses. b Rmerge(I)
) ∑hlkjIhlk - 〈Ihkl〉j/∑hlkIhkl, where Ihkl is the measured intensity of the
reflection with indices hkl.




resolution range (Å) 8.0-1.7 8.0-1.7
completeness (working + test) (%) 94.1 92.6
no. of reflections (F > 2ó) 64762 63397
Ra (working set)/Rfree (test set) (%) 19.7/23.5 21.6/25.6
Rfree (test set size) (%) 5.1 5.1
estimated error in the Rfree value 0.004 0.005
no. of protein atoms (non-hydrogen) 3990 3999
no. of ligand and solvent atoms
(non-hydrogen)
180 181
B values from the Wilson plot (Å2) 21.4 23.1
mean B value (Å2)
overall 24.0 25.1
protein atoms 23.6 24.9
solvent atoms 32.6 32.0
cefoxitin atoms - 24.2
estimated coordinate error
(low-resolution cutoff of 5.0 Å)
Luzzati plot/óA (Å) 0.20/0.19 0.23/0.28
rms deviations from ideal values
bond lengths/bond angles (Å/deg) 0.006/1.3 0.007/1.3
dihedral angles/improper angles (deg/deg) 25.3/0.69 25.4/0.96
a R ) ∑hlkjjFohklj - jFchkljj/∑hlkFohkl, where jFohklj and jFchklj are the
observed and calculated structure factor amplitudes, respectively, for
reflection hkl belonging to the working set. Rfree is defined for reflection
hkl belonging to the test set.
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Lys234-Thr235-Gly236 triad on strand â3. The bottom is
closed by an ¿-loop bearing helix R7, and containing the
Glu166 and Asn170 residues that point into the active site.
Maps constructed with data from 20 to 1.7 Å clearly
showed a significant electron density in the catalytic cleft
of each monomer that can be attributed to one citrate anion
resulting from crystallization conditions (Figure 2a). As
observed in other â-lactamase crystallographic structures,
where sulfate or acetate ion is also present in the catalytic
pocket, citrate has no impact on the active site structure. The
citrate molecule interacts with the hydroxyl oxygen atoms
of both Ser70 and Ser130 residues and with a Na+ ion or a
water molecule, which is itself in contact with the Tyr274
hydroxyl group. Citrate also interacts with the side chains
of Thr235 and Arg244, both bordering the active site and
generally considered to be involved in the positioning of
substrates (Figure 1b). Those multiple interactions can
explain the different kinetic results observed when experi-
ments are performed in sodium acetate or citrate. With
cephalothin at pH 5 in either 100 mM sodium acetate or
100 mM sodium citrate, kinetic experiments reveal Km values
of 42 íM or higher than 1 mM, respectively, with unchanged
Vmax values, suggesting that citrate ions behave as competitive
inhibitors.
The BS3 crystal structure is also solvated by 152 ordered
water molecules. Two of these solvent molecules, mainly
located in the first coordination shell, are very well conserved
in all class A â-lactamase structures. Wat302, the so-called
hydrolytic class A water molecule, interacts with the active
Ser70 and Glu166 of the ¿-loop. The other conserved
molecule, Wat303, interacts with the oxyanion hole formed
by the NH groups of the Ala237 and nucleophilic Ser70
residues, and also with an oxygen atom of a carboxylate
group of the citrate ion.
Comparison with the B. licheniformis 749/C â-Lactamase.
Since the amino acid sequences of B. licheniformis 749/C
and BS3 differ by only seven point mutations, the structures
of the two enzymes are very similar with an rms deviation
of 0.36 Å2 between the equivalent backbone atoms.
According to the ABL numbering (22), six mutations (Ala59
f Thr, Val187 f Ala, Arg191 f Gln, Asp227 f Glu,
Ala238 f Gly, and Met287 f Leu) occur in the R/â-domain,
and one occurs in the R-domain at the N-terminal R5 helix
(Ala133 f Thr) (23). Residues 59, 191, and 227 are on the
surface of the protein and do not exhibit any significant
interaction either in BS3 or in 749/C. Residues 133, 187,
and 287 are completely buried, and the latter two are involved
in hydrophobic clusters. The replacement of Met287 in 749/C
with the smaller Leu in the BS3 leads to a slight displacement
of the polypeptide chain of the R10-â3 loop and of residues
250-253, just after strand â4. Similarly, the Thr133 f Ala
mutation also induces a small shift of residues 100-104.
FIGURE 1: (a) Ribbon diagram of the BS3 â-lactamase with secondary structure assignments computed with the program DSSP (20) and
identification of the conserved residues of the active site, including the nucleophilic serine S* residue. (b) Stereoview of the active site of
BS3 with the two essential water molecules, Wat302 and Wat303 (black). The other solvent molecules are denoted Cit300 and Na301 for
the citrate and Na+ ions (gray), respectively, and their hydrogen bonds are represented by dashed lines. This figure was produced using
MolScript (21).
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Residue 187 participates in a spatially aligned triad in BS3
(Thr59, Phe47, and Ala187) and in 749/C (Ala59, Phe47,
and Val187), with two sterically compensating mutations.
The last mutation (Ala238 f Gly) is on strand â3, limiting
the active site. The side chain of the alanine 238 residue
points to the bottom of the catalytic pocket. Its small size
and lack of polar or charged properties do not allow major
interactions with substrates. The substitution of an alanine
in position 238 with a glycine residue does not perturb the
active site geometry and is unlikely to modify significantly
the enzymatic activity profile.
BS3-Cefoxitin Structure. The crystal structure of the
BS3-cefoxitin adduct was also determined by molecular
replacement, and the two molecules occupying the asym-
metric unit were refined separately to 1.7 Å resolution (Table
3). As for the free enzyme, the two monomers are very
similar (with an rms deviation of 0.26 Å between the
equivalent backbone atoms) and their active sites nearly
superimposable; the following discussion only refers to the
structure of one monomer. The overall structure of the adduct
closely resembles that of the free enzyme (with an rms
deviation of 0.26 Å between the equivalent N, CR, C, and
O atoms) except for the N- and C-terminal residues
[Gly238-Ser240, Pro254 and Lys255, and especially Pro167-
Val172 (Figure 2b)]. The rms deviation of these backbone
regions is 2 or 3 times larger than the overall rms deviation
which is within the range of experimental error. The
N-terminal Asp31 and Asp32 residues, the C-terminal
Ala289, and the Pro254 and Lys255 residues of the â4-â5
loop are all far from the active site and their side chains
totally exposed to the solvent without any constraint due to
atoms of their own or symmetric molecules. Their positions
are also different in the B. licheniformis 749/C â-lactamase.
By contrast, the Pro167-Val172 region includes a portion
of the ¿-loop that borders the catalytic cleft, and the different
conformation observed in the adduct structure is a direct
consequence of cefoxitin binding (Figure 3). This new
¿-loop conformation also induces a slight displacement of
the lower part of strand â3 defined by the Gly238 and Ser240
residues.
The electron density in the adduct crystal structure un-
ambiguously reveals a covalent acyl-enzyme adduct where
cefoxitin has lost its C-3′ leaving group (Figure 2c). Carbonyl
O9 of the open â-lactam ring replaces Wat303 in the
oxyanion hole at a distance of 2.9 Å from both main chain
nitrogens of Ser70 and Ala237 (Figure 4a). The cefoxitin
carboxylate oxygen atoms form only one hydrogen bond to
Thr235 OG1 at a distance of 2.6 Å (Table 4).
In all known high-resolution acyl-enzyme structures of
the penicilloyl serine transferase family, a similar binding
mode of the 7(or 6)â-amido linkage of cephalosporins (or
penicillins) is observed. In the acyl-enzyme adduct formed
by penicillin G and the TEM-1 Glu166 f Asn inactive
mutant (24) (PDB entry 1FQG), the 6â-amido nitrogen and
oxygen atoms are hydrogen bonded to the main chain
carbonyl oxygen atom of Ala237 and to the amide nitrogen
atom of Asn132, respectively (Figure 4b). With phosphonate
or boronate inhibitors displaying an amidated side chain, the
same type of orientation is also found, in class A (25-27)
(PDB entries 1BLH, 1AXB, 1ERM, 1ERQ, and 1ERO) or
class C (28-30) (PDB entries 1BLS, 1FSY, and 1IEM)
â-lactamases. The acyl-enzyme adducts formed by either
the class C â-lactamase from E. coli AmpC and ceftazidime
or loracarbef (30, 31) (PDB entries 1IEL and 1FCN) or the
DD-carboxypeptidase from Streptomyces R61 and cepha-
losporin C (32), cephalothin, or cefotaxime (33) (PDB entries
1CEG and 1CEF) also exhibit similar binding schemes
between the 7â-amido group and Ala318 or Thr301 (equiva-
lent to class A residue 237) and Asn152 or Asn161 (equiv-
alent to class A residue 132). In the BS3-cefoxitin acyl-
enzyme adduct, the steric constraints between the Asn132
side chain and the methoxy group on the R-face of the
â-lactam ring force this group further into the catalytic
pocket, where it interacts with the Ser70 and Lys73 residues.
Because of the tetrahedral character of C7 and the steric bulk
of the methoxy group, the 7â side chain can no longer adopt
the typical conformation characterized by the interactions
involving the peptide-like moiety (N and O) of the cefoxitin
side chain and the Asn132-Ala237 pair. The 7â-carbonyl
points into the active site in such a way that the oxygen atom
FIGURE 2: (a) Stereoview of the 2Fo - Fc electron density map
(contoured at the 1.4ó level) of the unliganded BS3 enzyme showing
the two essential water molecules (WAT 302 and WAT 303) and
the citrate ion (CIT 300) in the active site. (b) Stereoview of the
Fo - Fc electron density map of the BS3-cefoxitin adduct showing
the ¿-loop region of residues 165-171. Atoms from residues 166
to 170 of each monomer were omitted from the Fc calculation, and
the contour level is 3.0ó. (c) Stereoview of the Fo - Fc electron
density map of the BS3-cefoxitin adduct with the cefoxitin moiety
(CFX 300) covalently bound to the active serine (SER 70). The
cefoxitin atoms of each monomer were omitted from the Fc
calculation, and the contour level is 3.0ó.
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is 2.6 Å from Glu166 OE1 and the hydrolytic Wat302 water
molecule disappears. Accommodation of the 7â side chain
of cefoxitin in the acyl-enzyme intermediate results in a
modification of the Asn170 side chain conformation whose
ł1 and ł2 torsional angles vary from -63.9° and -47.0° in
the free enzyme to -170.1° and 34.2° in the cefoxitin adduct,
respectively. This modification induces a slight motion of
the ¿-loop (Pro167-Val172) (Figure 3).
At present, the only known acyl-enzyme adducts exhibit-
ing a substrate-binding mode similar to that of the BS3-
cefoxitin complex are the class C â-lactamase AmpC-
moxalactam (31, 34) (PDB entry 1FCO for the wild-type
enzyme and PDB entry 1I5Q for the Asn152 f Ala mutant)
and PBP2x-cefuroxime adducts (35) (PDB entry 1QMF).
The wild-type AmpC-moxalactam crystal structure, with
two molecules in the asymmetric unit, reveals two different
positionings of moxalactam in the active site. In the first
monomer, the substrate conformation is similar to that of
cefoxitin in BS3, but in the second, the oxacephem ring has
rotated by almost 180° around the C6-C7 bond, leading to
van der Waals overlaps between Asn152 (equivalent to BS3
Asn132) and the R-methoxy group of moxalactam. This latter
conformation would be impossible with a class A â-lacta-
mase because of steric hindrance between the 7(R)(â) side
FIGURE 3: Superimposed active sites of the unliganded BS3 enzyme (gray) and of the acyl-enzyme adduct with cefoxitin (white), showing
the ¿-loop (E166-N170) deformation and the shift of strand â3 (A237-A240) induced by cefoxitin.
FIGURE 4: (a) Stereoview of the active site of the BS3-cefoxitin acyl-enzyme adduct. (b) Stereoview of the active site of the TEM-1-
penicillin G acyl-enzyme adduct (24). Both stereoviews have the same orientation, and dashed lines represent hydrogen bonds.
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chain and the ¿-loop. In the PBP2x-cefuroxime structure,
the 7â-amido group of the inactivator adopts an orientation
equivalent to that observed here for cefoxitin. However, in
this case, the 7â-amido conformation is constrained rather
by the steric hindrance of the 7â side chain than by the 7R
substituent which is a mere hydrogen atom in cefuroxime.
This acyl intermediate also induces movements of the active
site bottom (Gln452) and of strand â3 (Thr550-Ala551-
Gln552).
It is important to emphasize that in the BS3-cefoxitin
structure, the R-methoxy group does not directly cause the
conformational change but that it does so by influencing the
7â side chain orientation. In agreement with that, and as
observed by NMR experiments, the 7â-formamidoyl-7R-
methoxycephalosporanic acid does not induce structural
modifications in the B. licheniformis 749/C â-lactamase.2
Indeed, in this case, there is no steric incompatibility between
the short 7â side chain and the ¿-loop. Nevertheless, for all
compounds bearing a 7R-methoxy group, all steps of the
hydrolysis pathway are severely impeded. To both accom-
modate the 7R and eventually the 7â side chains into the
catalytic pocket and bring the substrate in a suitable position
for the nucleophilic attack, the â-lactamase must necessarily
undergo some conformational changes. The catalytic mech-
anism leading to formation of the acyl-enzyme complex is
thus greatly impaired. Comparatively, the kcat/Km value
determined for BS3 and cephalothin is more than 105-fold
larger than with a similar substrate bearing a 7R-methoxy
group (Table 1). Similarly, the deacylation process is also
impaired by the introduction of a new hydrogen bonding
scheme, which directly involves essential amino acid residues
such as Ser70, Lys73, and Glu166, and by the disappearance
of the hydrolytic water molecule.
The flexibility of class A â-lactamase active site has also
been illustrated by the structure of the intermediate formed
after acylation of the TEM-1 â-lactamase by imipenem (36)
(PDB entry 1BT5). This structure revealed a shift of the
Met129-Asp131 loop accompanied by a conformational
rearrangement of Ser130 forced by the 6R-1(R)-hydroxyethyl
substituent. In that case, as in that of the TEM-1-6R-
(hydroxymethyl)penicillanic acid adduct (37) (PDB entry
1TEM), it is essentially the deacylation step that is deficient
because of the displacement of the hydrolytic water molecule
by the substrate in the acyl-enzyme adduct.
DISCUSSION
To highlight the role suggested for the residue at position
132 (or the equivalent residue), kinetic parameters character-
izing the interactions between â-lactams and some penicilloyl
serine transferases are listed in Table 5. Only three repre-
sentative â-lactams (penicillin G, cephalothin, and cefoxitin)
are considered, and the structures of all the described
enzymes are known, except for that of the class A â-lacta-
mase from Streptomyces claVuligerus. As the kinetic data
are compiled from independently published reports and were
thus determined under different conditions, only a semi-
quantitative analysis can be performed. Nevertheless, it
clearly appears that the relative activities of all enzymes
against penicillin G and cephalothin are much higher than
against cefoxitin, except for that of the S. claVuligerus class
A â-lactamase (43) and for the Streptomyces K15 DD-
transpeptidase (45, 48) (PDB entry 1SKF). For these two
enzymes, where Asn132 is replaced with Gly and Cys,
respectively, the steric constraints in the active site are
significantly reduced and result in an easier accommodation
of the R-methoxy group. On the other hand, without the
stabilizing interactions between the 6â or 7â side chain of
classical compounds such as penicillin G or cephalothin and
Asn132, formation of the acyl-enzyme adduct is greatly
impaired, as highlighted by the very poor acylation rates
displayed by all substrates of the S. claVuligerus enzyme,
2 Misselyn-Bauduin, A.-M. (1989) Ph.D. Thesis, University of Lie`ge,
Lie`ge, Belgium.
Table 4: Key Contacts in the BS3-Cefoxitin Adducta
protein/solvent atom distance (Å)
cefoxitin atom
C7 Ser70 OG 2.4
C8 Ser70 CB 2.4
O9 Ser70 N 2.9
O9 Ser70 OG 2.3
O9 Ala237 N 2.9
O9 Ala237 O 3.1
carboxylate
O13 Ser130 OG 3.3
O13 Wat1344 O 2.8
O14 Thr235 OG1 2.6
O14 Gly236 N 3.4
O14 Arg244 NH1 3.5
7R side chain (R′′)
O16 Ser70 OG 2.3
O16 Lys73 NZ 2.6
O16 Ser130 OG 3.1
C17 Ser130 O 2.9
C17 Asn132 OD1 2.8
7â amido group
O21 Ser70 OG 2.9
O21 Glu166 OE1 2.6
a The distances given are for the first monomer. The rms value for
cefoxitin atoms in the two monomers when CR atoms are superimposed
is 0.14 Å.
Table 5: Kinetic Parameters
kcat/Km (mM-1 s-1)
enzymea penicillin G cephalothin cefoxitin motif
BS3b 83000 14000 0.060 SDN132/KTGA237
TEM-1 84000 570 0.006 SDN132/KSGA237
MFO 1000 1900 0.016 SDN132/KTGS237
NMC-A 9300 15200 62.3 SDN132/KTGS237
SCLA 32 0.7 97 SDG132/KTGA237
P99 23000 20000 2500 YAN152/KTGS318
k2/K′ (M-1 s-1)
enzymea penicillin G cephalothin cefoxitin motif
K15 150 2 860 SGC98/KTGS216
R61 13000 3000 1500 YSN161/HTGT301
PBP2x 58000 NDc 700 SSN397/KSGT550
a Second-order rate constants kcat/Km for the acylation of class A
â-lactamases from B. licheniformis BS3, E. coli TEM-1 (38, 39),
Mycobacterium fortuitum (MFO) (40, 41), E. coli NOR-1 (NMC-A)
(42), and S. claVuligerus (SCLA) (43) and for the class C â-lactamase
from Enterobacter cloacae P99 (44). For the DD-peptidases from
Streptomyces K15 (45) and Streptomyces R61 (46) and for the PBP2x
from S. pneumoniae (47), the second-order rate constants are described
by the k2/K′ values. b Kinetic parameters were determined at 30 °C in
50 mM sodium phosphate at pH 7. c Not determined, but k2/K′ values
for cephaloglycin, cephaloridine, and cefotaxime were determined to
be 12 400, 93 000, and 162 000 M-1 s-1, respectively (47).
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where the Gly132 residue is unable to form a hydrogen bond
with the substrate side chain. For the class A NMC-A
â-lactamase, the relative decrease of kcat/Km for cefoxitin
compared to that of cephalothin is markedly less important
than for the other class A enzymes characterized by a Ser130-
Asp131-Asn132 motif (42). This difference in the substrate
profile is due to an enlargement of the catalytic pocket,
resulting of a shift of Asn132 of 1 Å away from strand â3
(49) (PDB entry 1BUE). As shown in the acyl-enzyme
structure of the NMC-A-imipenem adduct (50) (PDB entry
1BUL), the new position of Asn132 results not only in a
more accessible active site for substrates with C6(C7)-R-
substituents such as imipenem and cefoxitin but also in new
possible hydrogen bonds between the residue 132 side chain
and these substituents.
Some conclusions about the acylation pathway can be
tentatively drawn on the basis of the structure of the BS3-
cefoxitin adduct. If cephalothin is docked in the BS3 active
site using the R61-cephalothin and/or the TEM-1-penicillin
G adducts as templates, the absence of the C7 methoxy group
allows a slight rotation around the antibiotic C7-C8 bond.
It is possible to position the â-lactam carbonyl oxygen in
the oxyanion hole and to simultaneously create interactions
between the C4 carboxylate and Thr235, and between the
antibiotic side chain CO and Asn132. The importance of this
latter interaction is underlined by the observation that
7-aminocephalosporanic acid is a very poor substrate of the
closely related 749/C enzyme (kcat/Km ) 330 M-1 s-1, i.e.,
0.01% of that of cephalothin) and of all class A â-lactamases
(51). It can thus be hypothesized that the interaction between
the â-lactam side chain and Asn132 is crucial for a
catalytically efficient positioning of the cephalosporin â-lac-
tam ring. With cefoxitin, this favorable interaction is made
impossible by the presence of the 7R-methoxy group, and
in addition, the new interactions between this group and
Ser70 and Lys73, with the disappearance of the catalytic
water molecule, create important electronic perturbations in
the active site, thus severely impairing both acylation and
deacylation processes.
Conversely, the Enterobacter cloacae P99 class C â-lac-
tamase (52) (PDB entry 2BLT), the Streptomyces R61 DD-
carboxypeptidase (53) (PDB entry 3PTE), and the Strepto-
coccus pneumoniae PBP2x (35) seem to be better adapted
to the presence of an R-methoxy side chain than the class A
â-lactamases (44, 46, 47). In all these structures, the
conformation of the asparagine residue (Asn152, Asn161,
and Asn397, respectively) is less restrained than the equiva-
lent class A Asn132. The conformational freedom of the
latter is strongly reduced by the class A ¿-loop (in particular
by Glu166 as shown by the AmpC-moxalactam structure)
and by the loop of residues 104 and 105 which covers the
Ser130-Asp131-Asn132 motif at the entrance of the catalytic
pocket.
It is also interesting to note that 6-aminopenicillanic acid
is generally a much better substrate than 7-aminocepha-
losporanic acid for class A â-lactamases (51). This suggests
that the interaction between the Asn132 NH2 group and the
antibiotic side chain CO is less important with the penam
class of substrates, a conclusion which is reinforced by the
fact that the cephalosporinase activity of the Asn132 f Ser
mutant of the S. albus G â-lactamase is much more impaired
than its penicillinase activity (54). However, the very poor
activity of both the Asn132 f Ala mutant of the same
enzyme and of the S. claVuligerus â-lactamase toward all
the substrates underlines the importance of the formation of
a hydrogen bond with the residue in position 132. On the
other hand, a better cephalosporinase activity can be related
to the presence of an hydroxylated residue at position 237
(Table 5). A serine or threonine residue, just after the Lys-
Thr(Ser)-Gly motif, would facilitate the binding of cepha-
losporins in the catalytic pocket by interacting with their
carboxylate group. In the structures of the adducts formed
by the Streptomyces R61 DD-carboxypeptidase and cephal-
othin or cephalosporin C, the carboxylate oxygen atoms are
always hydrogen-bonded to the hydroxyl groups of the
threonine residue of the His298-Thr299-Gly300 triad and
Thr301. The same interactions occur in the PBP2x-cefur-
oxime acyl-enzyme adduct but with a serine residue instead
of a threonine in the Lys547-Ser548-Gly549 motif.
In short, the previously discussed observations underline
two major anchor sites of â-lactam substrates in the catalytic
pocket of penicilloyl serine transferases. The first one implies
the existence of the interaction between the Asn132 residue
(or its equivalent) and the 7(6)â side chain and the second
one the binding of the â-lactam carboxylate. The combination
of these two interactions, which together contribute to an
adequate substrate positioning, is probably one of the major
factors that determine the catalytic efficiency of the enzyme
toward its â-lactam substrates.
In light of all known three-dimensional structures, and
especially of the structures of the adducts, a better under-
standing of kinetic results emerges which would lead to a
more valuable estimation of the structure-activity relation-
ship.
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